Attorney General Platkin, Labor Commissioner Asaro-Angelo File Suit Against JTTT Truck Driving School for Misclassifying Instructors

Lawsuit Seeks Back Wages, Penalties, Fines, and End of Misclassification of Employee Instructors as Independent Contractors.

AG Platkin Returns to Federal Courts to Support Title IX

Attorney General Matthew J. Platkin announced that New Jersey, California, and Pennsylvania co-led two amicus briefs on behalf of a multistate coalition in federal appellate courts to further defend Title IX’s protections of all students, including LGBTQ+ students, from gender-based harassment and sex discrimination, and to reverse a preliminary injunction that could affect certain schools in their states.

Attorney General Platkin and Multistate Coalition Secure $4.5 Million from Enzo Biochem for Failing to Protect Health Data

Data Breach of Lab Testing Company Exposed Health Information of About 331,600 New Jerseyans.

NJ Investors Urged to Redeem Funds Remaining on “Abra” Trading & Lending Platform

Crypto Investment Company Winds Down U.S. Operations Following Multi-State Securities Investigation   For Immediate Release: August 12, 2024 Office of the Attorney General- Matthew J. Platkin, Attorney GeneralDivision of Consumer Affairs- Cari Fais, Acting...

Attorney General Platkin Announces Settlement with Video Sharing Service

Attorney General Matthew J. Platkin joined 29 other Attorneys General today in announcing a settlement resolving potential consumer protection and Federal Trade Commission (“FTC”) Endorsement Guideline violations by Baron App, which does business as Cameo, a platform for hiring celebrities to create personalized video messages.

AG Platkin Submits Comment Letter in Support of Federal Government’s Proposed Rescheduling of Marijuana

Attorney General Matthew J. Platkin submitted a comment letter on Monday to the federal Drug Enforcement Administration (DEA) supporting the DEA’s proposed rule that would reschedule marijuana under the Controlled Substances Act, from Schedule I, which is reserved for highly addictive and dangerous substances like heroin, to Schedule III, in recognition of marijuana’s potential for therapeutic and medical benefits and lower risk for abuse.

Translate »